These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7972989)

  • 1. Fluticasone propionate in children.
    Russell G
    Respir Med; 1994 Aug; 88 Suppl A():25-9. PubMed ID: 7972989
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials of high-dose fluticasone propionate.
    Greening AP
    Respir Med; 1994 Aug; 88 Suppl A():17-22; discussion 22-3. PubMed ID: 7972988
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
    Barnes NC; Marone G; Di Maria GU; Visser S; Utama I; Payne SL
    Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
    Holliday SM; Faulds D; Sorkin EM
    Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone propionate v beclomethasone dipropionate (BDP) in moderate to severe asthma.
    O'Driscoll R
    Thorax; 1994 Apr; 49(4):385. PubMed ID: 8202917
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
    Fabbri L; Burge PS; Croonenborgh L; Warlies F; Weeke B; Ciaccia A; Parker C
    Thorax; 1993 Aug; 48(8):817-23. PubMed ID: 8211872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma.
    Leblanc P; Mink S; Keistinen T; Saarelainen PA; Ringdal N; Payne SL
    Allergy; 1994 May; 49(5):380-5. PubMed ID: 8092438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate.
    van As A; Bronsky EA; Dockhorn RJ; Grossman J; Lumry W; Meltzer EO; Seltzer JM; Rogenes PR
    J Allergy Clin Immunol; 1993 Jun; 91(6):1146-54. PubMed ID: 8509578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
    Bootsma GP; Dekhuijzen PN; Festen J; Mulder PG; van Herwaarden CL
    Thorax; 1995 Oct; 50(10):1044-50. PubMed ID: 7491551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma.
    Robroeks CM; van de Kant KD; van Vliet D; Kester AD; Hendriks HJ; Damoiseaux JG; Wodzig WK; Rijkers GT; Dompeling E; Jöbsis Q
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):601-7. PubMed ID: 18592826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler.
    Lundback B; Alexander M; Day J; Hebert J; Holzer R; Van Uffelen R; Kesten S; Jones AL
    Respir Med; 1993 Nov; 87(8):609-20. PubMed ID: 8290745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
    Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ; Currie GP; Lipworth BJ
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone versus salmeterol/low-dose fluticasone for long-term asthma control.
    Heyneman CA; Crafts R; Holland J; Arnold AD
    Ann Pharmacother; 2002 Dec; 36(12):1944-9. PubMed ID: 12452759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone versus beclomethasone or budesonide for chronic asthma.
    Adams N; Bestall JM; Jones PW
    Cochrane Database Syst Rev; 2002; (1):CD002310. PubMed ID: 11869636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the cost effectiveness of alternative prophylactic therapies in childhood asthma.
    Booth PC; Wells NE; Morrison AK
    Pharmacoeconomics; 1996 Sep; 10(3):262-8. PubMed ID: 10163573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.